Peroxisome proliferator-activated receptor gamma polymorphism is related to peak bone mass: The JPOS study
Tamaki J et al. – Study concludes that the peroxisome proliferator-activated receptors gamma (PPARγ) polymorphism C161T is associated with low peak bone mass. Methods- Study examines the impact of PPARγ C161T polymorphism on bone mineral density (BMD) and its change
- A baseline survey in 1996 and a 10-yr f/u survey
- 1,217 participants were analyzed cross-sectionally, while longitudinal analysis was performed on 563 women
Results- Total hip and femoral neck BMDs were higher for CC genotype than for CT/TT genotypes among 664 premenopausal women
- Compared to the CC genotype, the odds ratio for osteopenia or osteoporosis at the femoral neck was 1.98 for premenopausal CT/TT genotypes
- Change of BMD at either skeletal site during the f/u period was not different for either menstrual status
[more...]
|
|
|
